Harpoon Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
611 Gateway Boulevard, Suite 400, South San Francisco, California

Insiders trading volume in the past year

Harpoon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ansbert Gadicke 10%+ Owner $146M May 28, 2021
New Leaf Ventures III, L.P. 10%+ Owner $21M Jan 11, 2021
Joanne L. Viney Director $484K Apr 1, 2023
Alan Colowick Director $378K Apr 1, 2023
Merck & Co., Inc. 10%+ Owner $23K +$492M Mar 11, 2024
Mark Chin Director $0 Mar 8, 2024
Holger Wesche Chief Scientific Officer Jan 28, 2022
Lauren P. Silvernail Director Mar 11, 2024
Andrew R. Robbins Director Mar 11, 2024
Ronald Hunt Director, 10%+ Owner Mar 8, 2024
New Leaf Biopharma Opportunities II, L.P. Director, 10%+ Owner Mar 11, 2024
Natalie Sacks Chief Medical Officer Jan 28, 2022
Jonathan G. Drachman Director Mar 8, 2024
Joseph S. Bailes Director Mar 11, 2024
Luke Nathaniel Walker Chief Medical Officer Mar 11, 2024
Julia Marie Eastland President and CEO, Director Mar 11, 2024
Scott Dunseth Myers Director Mar 11, 2024
Georgia Erbez Chief Financial Officer Jan 28, 2022
Frank J. Lanza Principal Fin. & Acctng Ofc. Mar 11, 2024
James B. Bucher Chief Legal Officer Mar 11, 2024

Recent Insider Transactions by Companies or Individuals for Harpoon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.